EQUITY RESEARCH MEMO

Delveinsight Business Research Group

Generated 5/24/2026

Executive Summary

Conviction (model self-assessment)85/100

DelveInsight Business Research Group is a leading Indian market research and consulting firm specializing in pharma, biotech, and medtech intelligence. Founded in 2014, the company leverages AI-driven epidemiology platforms and a repository of over 7,000 reports to provide data-rich forecasts, KOL profiling, and competitive analysis across 27 therapeutic areas. Serving a global clientele of pharma and biotech companies, it supports pipeline, launch, and commercial strategies with customized insights. DelveInsight has established itself as a trusted partner in the life sciences intelligence space, with a strong foothold in oncology, rare diseases, and neurology. Its platform-based business model and continuous investment in AI and data analytics position it well to capture growing demand for evidence-based market intelligence. With an estimated 200-500 employees and a private funding structure, the company is poised for sustained growth as the life sciences sector increasingly relies on data-driven decision-making. DelveInsight's ability to integrate real-world evidence with predictive modeling offers a competitive edge in an expanding market.

Upcoming Catalysts (preview)

  • Q1 2027Launch of Next-Gen AI Epidemiology Platform80% success
  • Q2 2027Expansion into Gene Therapy and Cell Therapy Market Intelligence70% success
  • Q3 2026Strategic Partnership with Top-20 Pharma for Custom Analytics Suite60% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)